ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

0J7G Hutchison China Meditech Ltd

33,29
0,00 (0,00%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Hutchison China Meditech Ltd 0J7G London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 33,29 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
33,29 33,29
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/1/202408:00RNSNONHutchmed (China) Limited Sovleplenib NDA Granted Priority..
29/12/202309:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
29/12/202309:30UKREGHutchmed (China) Limited Total Voting Rights
21/12/202311:00UKREGHutchmed (China) Limited Overseas Regulatory Announcement
13/12/202308:00RNSNONHutchmed (China) Limited Inclusion in National Reimbursement..
07/12/202311:04UKREGHutchmed (China) Limited Overseas Regulatory Announcement
01/12/202308:00RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
30/11/202309:30UKREGHutchmed (China) Limited Total Voting Rights
09/11/202308:00UKREGHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM)..
24/10/202310:30UKREGHutchmed (China) Limited Vesting of awards under the LTIP
16/10/202310:30RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
29/9/202310:30UKREGHutchmed (China) Limited Total Voting Rights
29/9/202310:30RNSNONHutchmed (China) Limited NDA Submission for Fruquintinib in..
14/9/202310:30UKREGHutchmed (China) Limited Director's Share Dealing
12/9/202310:30RNSNONHutchmed (China) Limited Phase IIIb Savolitinib Results at..
12/9/202308:00RNSNONHutchmed (China) Limited Patient Enrollment Completed for..
31/8/202310:30UKREGHutchmed (China) Limited Total Voting Rights
29/8/202308:00RNSNONHutchmed (China) Limited BTD in China for Savolitinib for..
21/8/202308:00UKREGHutchmed (China) Limited Sovleplenib Phase 3 Study Meets..
07/8/202310:30UKREGHutchmed (China) Limited Exercise of Share Options by a..
31/7/202313:00UKREGHutchmed (China) Limited Interim Results and Business..
20/7/202308:00RNSNONHutchmed (China) Limited Breakthrough Therapy Designation..
13/7/202310:30UKREGHutchmed (China) Limited Changes to Board and Technical..
10/7/202308:00RNSNONHutchmed (China) Limited Phase 1 Study of HMPL-415 Initiated
29/6/202310:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
26/6/202310:30UKREGHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year..
16/6/202308:00UKREGHutchmed (China) Limited Phase III FRESCO-2 Results in The..
15/6/202316:39UKREGHutchmed (China) Limited MAA of Fruquintinib Validated by..
09/6/202311:30RNSNONHutchmed (China) Limited HUTCHMED Highlights Presentations..
06/6/202311:00UKREGHutchmed (China) Limited LTIP and Share Option Scheme
31/5/202310:30UKREGHutchmed (China) Limited Total Voting Rights
26/5/202308:00UKREGHutchmed (China) Limited Fruquintinib NDA Granted Priority..
26/5/202308:00RNSNONHutchmed (China) Limited HUTCHMED Highlights Presentations..
17/5/202310:30UKREGHutchmed (China) Limited Standard form for notification of..
12/5/202314:15UKREGHutchmed (China) Limited Annual General Meeting Poll Results
12/5/202310:30UKREGHutchmed (China) Limited Board of Directors and Board..
10/5/202310:30UKREGHutchmed (China) Limited Appointment of Independent NED
28/4/202310:30UKREGHutchmed (China) Limited Total Voting Rights

Dernières Valeurs Consultées

Delayed Upgrade Clock